Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CYTK · against 175 other Healthcare companies of similar size
Ranked #148 of 176 · scores higher than 16% of peers · safety percentile 16
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)25 peers with a safety percentile of 10–19, including CYTK · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CYTK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 171 reported | Not reported | 0.33× | — | — | 33% |
| BetaLower is better · 177 reported | 0.41 | 0.57 | 59% | 33% | |
| Current ratioHigher is better · 167 reported | 6.66× | 2.48× | 84% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 144 | 14.4B USD | 18 | 71 | |
| 145 | 14.9B EUR (≈$16.4B) | 17 | 52 | |
| 146 | 4.7B GBP (≈$6.1B) | 17 | 49 | |
| 147 | 379.9B INR (≈$4.6B) | 17 | 55 | |
| 148 | 8.7B USD | 16 | 26 | |
| 149 | 5.8B USD | 16 | 64 | |
| 150 | 9.3B USD | 15 | 64 | |
| 151 | 13.2B USD | 14 | 30 | |
| 152 | 16.9B USD | 14 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score